Newborn screening in South Africa: the past, present, and plans for the future

Abstract

Worldwide, comprehensive newborn screening (NBS) now includes a clinical examination at birth, hearing screening, pulse oximetry measurement for congenital heart defects, and biochemical screening to identify congenital disorders early in life, preventing irreversible damage, early mortality and enhancing overall health outcomes. This article provides a comprehensive overview of biochemical NBS in South Africa, outlining the history, current status, and future plans for NBS expansion. In South Africa, NBS is fragmented, with some investigations included in neonatal health assessments. Historically, biochemical NBS pilot projects in the country in the 1960s and 1980s focused on phenylketonuria and congenital hypothyroidism (CH). Despite showing initial promise, these programmes were discontinued, largely due to competing health priorities. The current status of biochemical NBS in South Africa is discussed, both for the state and private healthcare sectors, which collectively screen approximately 0.5% of births annually. While recent clinical guidelines provide for a national biochemical NBS programme, implementation has been limited, and guideline adherence remains a challenge. A brief report of a two-day meeting held in Cape Town in February 2023 focusing on biochemical NBS for South Africa is provided. The meeting addressed the importance of NBS, technology requirements, and the need for a comprehensive demonstration project for biochemical CH NBS. Key challenges identified included early newborn post-delivery discharge, technical, logistical, and infrastructure issues, as well as limited financial and human resources. Meeting recommendations included the establishment of a National Advisory Panel for Biochemical NBS, and the development and implementation of a demonstration project for CH biochemical NBS in two provinces.

Keywords

Biochemical newborn screening / congenital hypothyroidism / rare diseases / South Africa

References

[1] World Health Organization. Management of birth defects and haemoglobin disorders. Report of a joint who-march of dimes meeting. Geneva, Switzerland, 17-19 May 2006. Available from: https://iris.who.int/bitstream/handle/10665/43587/9789241594929_eng.pdf?sequence=1 [Last accessed on 27 Feb 2024]

[2] Malherbe HL,Blencowe H,Aldous C.A review of key terminology and definitions used for birth defects globally.J Community Genet2023;14:241-62 PMCID:PMC10272040

[3] El-Hattab AW,Sutton VR.Newborn screening: history, current status, and future directions.Pediatr Clin N Am2018;65:389-405

[4] Howson CP,Giugliani R.Universal newborn screening: a roadmap for action.Mol Genet Metab2018;124:177-83

[5] Maccready RA.Newborn phenylketonuria detection program in massachusetts.Am J Public Health Nations Health1964;54:2075-81 PMCID:PMC1255124

[6] Levy HL.Robert guthrie and the trials and tribulations of newborn screening.Int J Neonatal Screen2021;7:5 PMCID:PMC7838808

[7] Caggana M,Shahied SI,Hermerath CA.Newborn screening: from guthrie to whole genome sequencing.Public Health Rep2013;128:14-9 PMCID:PMC3730001

[8] Guthrie R.A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants.Pediatrics1963;32:338-43.

[9] Parker SP.The use of the dried blood spot sample in epidemiological studies.J Clin Pathol1999;52:633-9 PMCID:PMC501537

[10] Population screening by guthrie test for phenylketonuria in South-East Scotland. Report by the consultant paediatricians and medical officers of health of the S.E. Scotland hospital region.Br Med J1968;1:674-6 PMCID:PMC1985372

[11] Dussault JH,Laberge C,Guyda H.Preliminary report on a mass screening program for neonatal hypothyroidism.J Pediatr1975;86:670-4

[12] Pang S,Drash AL,New MI.Microfilter paper method for 17α-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia.J Clin Endocrinol Metab1977;45:1003-8

[13] Crossley JR,Smith PA.Dried-blood spot screening for cystic fibrosis in the newborn.Lancet1979;1:472-4

[14] Chace DH,Terada N,Roe CR.Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry.Clin Chem1993;39:66-71.

[15] Rashed MS,Bucknall MP.Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry.Pediatr Res1995;38:324-31

[16] Millington DS,Norwood DL.Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism.J Inherit Metab Dis1990;13:321-4

[17] Ellinwood NM.Newborn screening and the recommended uniform screening panel: optimal submissions and suggested improvements based on an advocacy organization’s decade-long experience.Am J Med Genet C Semin Med Genet2022;190:156-61

[18] Therrell BL,Loeber JG.Current status of newborn screening worldwide: 2015.Semin Perinatol2015;39:171-87

[19] Advisory Committee on Heritable Disorders in Newborns and Children. Recommended uniform screening panel. 2018. Available from: https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp [Last accessed on 27 Feb 2024]

[20] Padilla CD.Genetic services and testing in the Philippines.J Community Genet2013;4:399-411 PMCID:PMC3739853

[21] Sustainable Development Goal. Goal 3: ensure healthy lives and promote wellbeing for all and at all ages. Available from: http://www.un.org/sustainabledevelopment/health/ [Last accessed on 27 Feb 2024]

[22] Stats Sa. Statistical release P0302. Mid-year population estimates 2022. Available from: http://www.statssa.gov.za/publications/P0302/P03022022.pdf [Last accessed on 27 Feb 2024]

[23] Stats Sa. Statistical release P0305. Recorded live births 2021. Available from: http://www.statssa.gov.za/publications/P0305/P03052021.pdf [Last accessed on 27 Feb 2024]

[24] Dorrington R,Laubscher R. Rapid mortality surveillance report 2019 & 2020. Cape Town: South African Medical Research Council. 2021. Available from: https://www.samrc.ac.za/sites/default/files/attachments/2022-08/Rapid%20Mortality%20Surveillance%20Report%202019%262020.pdf [Last accessed on 27 Feb 2024]

[25] Wessels J,Bamford L.The updated South African national guideline for the prevention of mother to child transmission of communicable infections (2019).South Afr J HIV Med2020;21:1079 PMCID:PMC7433286

[26] Stats Sa. Statistical release P0318. General household survey 2022. Available from: https://www.statssa.gov.za/publications/P0318/P03182022.pdf [Last accessed on 27 Feb 2024]

[27] Pillay Y,Barron P.Impact of COVID-19 on routine primary healthcare services in South Africa.S Afr Med J2021;111:714-9

[28] Chuene TA.The readiness of public hospitals on the implementation of national health insurance in South Africa: a systematic review.Int J Soc Sci Res Rev2023;6:153-66

[29] Pauw TL.Catching up with the constitution: an analysis of national health insurance in South Africa post-apartheid.Dev South Afr2022;39:921-34

[30] Mukwena NV.Factors influencing the preparedness for the implementation of the national health insurance scheme at a selected hospital in Gauteng province, South Africa.BMC Health Serv Res2022;22:1006 PMCID:PMC9357321

[31] Murphy SD.The views of public service managers on the implementation of national health insurance in primary care: a case of Johannesburg health district, gauteng province, republic of South Africa.BMC Health Serv Res2021;21:969 PMCID:PMC8439954

[32] Michel J,Egger M.Universal health coverage financing in South Africa: wishes vs reality.J Glob Health Rep2020;4:e2020061

[33] National health insurance. Healthcare for all South Africans. Understanding national health insurance. Available from: https://www.hst.org.za/publications/NonHST%20Publications/Booklet%20-%20Understanding%20National%20Health%20Insurance.pdf [Last accessed on 27 Feb 2024]

[34] Malherbe HL,Aldous C.Need for services for the care and prevention of congenital disorders in South Africa as the country’s epidemiological transition evolves.S Afr Med J2015;105:186-8

[35] Arnold C,Hilary H. Genetic testing in emerging economies (GenTEE). Summary report. Ispra, Italy: Publications Office of the European Union. 2013. Available from: https://op.europa.eu/en/publication-detail/-/publication/12497195-cbaf-4af1-b22f-8057e5b9b411 [Last accessed on 27 Feb 2024]

[36] Malherbe HL,Woods D.The case for the genetic nurse in South Africa.J Community Genet2017;8:65-73 PMCID:PMC5386919

[37] Dorrington R,Laubscher R. Rapid mortality surveillance report 2018. Available from: https://www.samrc.ac.za/sites/default/files/attachments/2022-08/RapidMortalitySurveillanceReport2018.pdf [Last accessed on 27 Feb 2024]

[38] Malherbe HL,Woods D. The contribution of congenital disorders to child mortality in South Africa. Durban: Health Systems Trust. 2016; pp. 137-52. Available from: https://www.hst.org.za/publications/South%20African%20Health%20Reviews/12%20The%20contribution%20of%20congenital%20disorders%20to%20child%20mortality%20in%20South%20Africa.pdf [Last accessed on 27 Feb 2024]

[39] Kerber KJ,Johnson LF.South African child deaths 1990-2011: have HIV services reversed the trend enough to meet millennium development goal 4?.AIDS2013;27:2637-48

[40] Perin J,De Costa A.Systematic estimates of the global, regional and national under-5 mortality burden attributable to birth defects in 2000-2019: a summary of findings from the 2020 WHO estimates.BMJ Open2023;13:e067033 PMCID:PMC9887698

[41] Christianson A.Community genetics in South Africa.Community Genet2001;3:128-30

[42] Modell B.The history of community genetics: the contribution of the haemoglobin disorders.Community Genet1998;1:3-11

[43] Hitzeroth HW,Brill DC.Phenylketonuria in South Africa. A report on the status quo.S Afr Med J1995;85:33-6

[44] Jenkins T.Medical genetics in South Africa.J Med Genet1990;27:760-79 PMCID:PMC1017281

[45] Henderson HE,Schram J,Daneel A.Biochemical screening for inherited metabolic disorders in the mentally retarded.S Afr Med J1981;60:731-3

[46] Hitzeroth H.Screening for congenital hypothyroidism in South Africa. Report on a national workshop (1992)..S Afr Med J1994;84:106-8Available from: http://archive.samj.org.za/1994%20VOL%2084%20Jan-Dec/Articles/02%20February/1.17%20SCREENING%20FOR%20CONGENITAL%20HYPOTHYROIDISM%20IN%20SOUTH%20AFRICA%20-%20REPORT%20ON%20A%20NATIONAL%20WORKSHOP%201992.pdf [Last accessed on 29 Feb 2024]

[47] Bernstein RE.Neonatal screening for congenital hypothyroidism.S Afr Med J1979;56:1020-1

[48] Bernstein RE,Hitzeroth HW.Neonatal screening for congenital hypothyroidism. A decade's review, including South Africa.S Afr Med J1988;73:339-43.

[49] Bernstein RE.Congenital hypothyroidism. Clinicopathological aspects and biochemical screening.S Afr Med J1981;59:710-4.

[50] Philotheou A. Outcome for congenital hypothyroidism and early results of neonatal screening. In Paper presented at the 22nd Congress of the Society for Endocrinology, Metabolism and Diabetes of Southern Africa, Sun City, Bophutatswana, 20-23 March 1985.

[51] Lloyd-Puryear M,Berry SA,Bowdish B.Foundation of the newborn screening translational research network and its tools for research.Genet Med2019;21:1271-9

[52] Vorster BC. Presentation: national newborn screening programme to identify metabolism errors associated with mental retardation. IAEA-NECSA project SAF/6/004 & 006. Center for Human Metabolomics, Potchefstroom, South Africa: North-West University; 2016.

[53] National Department of Health. Human genetics policy guidelines for the management and prevention of genetic disorders, birth defects and disabilities. Pretoria: National Department of Health. 2001. Available from: https://www.gov.za/sites/default/files/gcis_document/201409/humangenetics0.pdf [Last accessed on 27 Feb 2024]

[54] Carrihill MM. An audit of the thyroid screening programme in the Peninsula Maternal and neonatal services (PMNS). J Endocrinol Metab Diabetes South Afr 2007;12:27. Available from: https://go.gale.com/ps/i.do?id=GALE%7CA168164786&sid=googleScholar&v=2.1&it=r&linkaccess=abs&issn=16089677&p=AONE&sw=w&userGroupName=anon%7E3d63112e&aty=open-web-entry [Last accessed on 27 Feb 2024]

[55] National Department of Health. Clinical guidelines for genetic services - 2021. Available from: https://knowledgehub.health.gov.za/elibrary/clinical-guidelines-genetics-services-2021 [Last accessed on 27 Feb 2024]

[56] Allanson ER.Quality-of-care audits and perinatal mortality in South Africa.Bull World Health Organ2015;93:424-8 PMCID:PMC4450707

[57] Horwood C,Phakathi S.A health systems strengthening intervention to improve quality of care for sick and small newborn infants: results from an evaluation in district hospitals in KwaZulu-Natal, South Africa.BMC Pediatr2019;19:29 PMCID:PMC6345064

[58] Niekerk AM, Cullis RM, Linley LL, Zühlke L. Feasibility of pulse oximetry pre-discharge screening implementation for detecting critical congenital heart lesions in newborns in a secondary level maternity hospital in the Western Cape, South Africa: the “POPSICLe” study.S Afr Med J2016;106:817-21

[59] Bezuidenhout JK,De Maayer T.Outcomes of newborn hearing screening at an academic secondary level hospital in Johannesburg, South Africa.S Afr J Commun Disord2021;68:e1-8 PMCID:PMC7876983

[60] Gina A,Jayawardena A,Arshad Q.Universal newborn hearing screening in South Africa: a single-centre study.BMJ Paediatr Open2021;5:e000976 PMCID:PMC7978244

[61] Kanji A.Newborn and infant hearing screening at primary healthcare clinics in South Africa designated as national health insurance pilot sites: an exploratory study.S Afr J Commun Disord2022;69:e1-7 PMCID:PMC8832026

[62] Conradie EH,Hendriksz CJ,Vorster BC.An overview of benefits and challenges of rare disease biobanking in Africa, focusing on South Africa.Biopreserv Biobank2021;19:143-50

[63] Dercksen M,Hendriksz CJ,Vorster BC.The advantages of rare disease biobanking: a localised source of genetic knowledge to benefit the South African rare disease community and related stakeholders worldwide.S Afr Med J2023;113:1512-3Available from: https://journals.co.za/doi/full/10.7196/SAMJ.2023.v113i12.1507 [Last accessed on 27 Feb 2024]

[64] Spooner E,Reddy T.Point-of-care HIV testing best practice for early infant diagnosis: an implementation study.BMC Public Health2019;19:731 PMCID:PMC6560857

[65] Christianson A,Kristoffersson U.Health needs assessment for medical genetic services for congenital disorders in middle- and low-income nations.J Community Genet2013;4:297-308 PMCID:PMC3739852

[66] Nacul LC,Alberg C.A toolkit to assess health needs for congenital disorders in low- and middle-income countries: an instrument for public health action.J Public Health2014;36:243-50 PMCID:PMC4041098